Status:
COMPLETED
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Portal Hypertension
Liver Diseases
Eligibility:
All Genders
18-82 years
Brief Summary
Liver cirrhosis is a chronic disease characterized by a progressive accumulation of fibrosis, loss of liver function and portal hypertension leading to several hemodynamic changes.The exact pathophysi...
Detailed Description
MR elastography, cardiac scan, phase contrast MRI of blood flow compared to LVC
Eligibility Criteria
Inclusion
- Patients with liver cirrhosis or portal hypertension Patient of more than 18 and less than 82 years of age
Exclusion
- Patients who are unable to give informed consent Patients with absolute contraindication for MRI Pregnant women Patient with severe hemodynamic comorbidity
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2021
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03443934
Start Date
April 1 2017
End Date
April 21 2021
Last Update
August 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Gastroenterology, Dept. of medicine. Hvidovre University Hospital
Hvidovre, Denmark, 2650